COMP <GO>
HSDT vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Solana Company (Class A) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: HSDT 3
— UNH 8
■ METRIC PARITY
LAST: $2.02 (-3.59%) • MKT CAP: $130.6M
options-implied-move
—
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
options-implied-move
7.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSDT VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSDT | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 88.31% | +7.69 | HSDT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 12.38% | -47.38 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -11.27% | 6.25% | -17.52 | UNH | /fcf-yield <GO> |
| Operating Margin | -60.00% | 5.32% | -65.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 3.53% | -63.53 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 5.40% | 3.33% | +2.07 | HSDT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 25.63 | 3.09 | +22.54 | HSDT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.9 | 55.1 | -17.20 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $130.6M | $359.43B | -$359.30B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSDT REV | UNH REV | HSDT GROSS % | UNH GROSS % | HSDT FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $548.0K | $447.57B | 98.0% | 88.7% | -$16.5M | $16.07B |
| FY 2024 | $520.0K | $400.28B | -11.9% | 88.3% | -$11.0M | $20.70B |
| FY 2023 | $605.0K | $371.62B | — | 89.6% | -$10.4M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSDT // BETA —
UNH // BETA 0.33